[1]
ODHAR, H.A. et al. 2024. VIRTUAL SCREENING OF FDA-APPROVED DRUGS BY MOLECULAR DOCKING AND DYNAMICS SIMULATION TO RECOGNIZE POTENTIAL INHIBITORS AGAINST MYCOBACTERIUM TUBERCULOSIS ENOYL-ACYL CARRIER PROTEIN REDUCTASE ENZYME. International Journal of Applied Pharmaceutics. 16, 1 (Jan. 2024), 261–266. DOI:https://doi.org/10.22159/ijap.2024v16i1.49471.